Relationship between Traditional Chinese Medicine Syndrome Elements and Prognosis of Patients with IgA Nephropathy

Objective It is not clear which Traditional Chinese Medicine- (TCM-) related elements affect primary IgA nephropathy (IgAN) progression. Here, we explored the risk factors, based on TCM syndrome elements, related to the prognosis of primary IgAN patients. Methods We analyzed patients with newly diagnosed, biopsy-proven IgAN at a single institution from December 2013 to September 2021. Basic clinical and pathological characteristics were assessed at the time of renal biopsy. The study endpoint was end-stage renal disease (ESRD: eGFR <15 ml/min per 1.73 m2, dialysis, or kidney transplantation) and/or eGFR decreased by >30% from baseline. Kaplan‒Meier survival analysis was used to explore the role of TCM syndrome elements in IgAN progression. Multivariate Cox regression analysis with adjustment for traditional risk factors was performed to explore TCM syndrome elements that may influence patient prognosis. The factors correlated with TCM syndrome elements in IgAN patients were further evaluated by logistic regression analysis. Results During a median follow-up of 22.0 months, 53 (12.5%) of the 423 included IgAN patients reached the study endpoint. The main IgAN disease location elements were the kidney, liver, and spleen. The main IgAN disease nature elements were Yin-deficiency and Qi-deficiency, dampness, Yang-deficiency, phlegm, and Blood-deficiency. Kaplan‒Meier analysis identified three disease locations (liver, spleen, and kidney) and four disease natures (Qi-deficiency, Yang-deficiency, phlegm, and dampness) as elements associated with poor renal survival in IgAN patients. In multivariate Cox regression analysis, baseline Yang-deficiency was an independent risk predictor of poor prognosis in primary IgAN patients (hazard ratio 2.338; 95% confidence interval [CI]: 1.208–4.525; P=0.012) after adjustment for traditional risk factors. Furthermore, logistic regression analysis identified being female (odds ratio [OR] 2.518; 95% CI: 1.538–4.122; P < 0.001), older age (OR 1.043; 95% CI: 1.022–1.065; P < 0.001), low hemoglobin levels (OR 0.984; 95% CI: 0.971–0.996; P=0.013), and cellular/fibrocellular crescents (OR 1.706; 95% CI: 1.068–2.728; P=0.026) as factors affecting Yang-deficiency in IgAN patients. Conclusions Yang-deficiency independently predicts the risk of poor prognosis in primary IgAN patients. Being female, older age, low hemoglobin levels, and cellular/fibrocellular crescents were independently associated with Yang-deficiency in IgAN patients.

[1]  B. Rovin,et al.  KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. , 2021, Kidney international.

[2]  Qiang Wan,et al.  Huangqi Guizhi Wuwu Decoction attenuates Podocyte cytoskeletal protein damage in IgA nephropathy rats by regulating AT1R/Nephrin/c-Abl pathway. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[3]  S. Shah,et al.  Long term outcome of immunoglobulin A (IgA) nephropathy: A single center experience , 2021, PloS one.

[4]  K. Nitta,et al.  Grading system utilising the total score of Oxford classification for predicting renal prognosis in IgA nephropathy , 2021, Scientific Reports.

[5]  Jiaxing Tan,et al.  Sex disparities in IgA nephropathy: a retrospective study in Chinese patients , 2020, International Urology and Nephrology.

[6]  Jing Ma,et al.  Epidemiology and risk factors for progression in Chinese patients with IgA nephropathy. , 2020, Medicina clinica.

[7]  Hong Zhang,et al.  External Validation of International Risk-Prediction Models of IgA Nephropathy in an Asian-Caucasian Cohort , 2020, Kidney international reports.

[8]  Zhangsuo Liu,et al.  External Validation of the International IgA Nephropathy Prediction Tool. , 2020, Clinical journal of the American Society of Nephrology : CJASN.

[9]  Jia Zhang,et al.  A Microcosmic Syndrome Differentiation Model for Metabolic Syndrome with Multilabel Learning , 2020, Evidence-based complementary and alternative medicine : eCAM.

[10]  Limin Liu,et al.  Renal survival and risk factors in IgA nephropathy with crescents , 2020, International Urology and Nephrology.

[11]  Shen Li,et al.  Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial , 2020, Trials.

[12]  Keiichi Matsuzaki,et al.  Evaluating a New International Risk-Prediction Tool in IgA Nephropathy. , 2019, JAMA internal medicine.

[13]  Xiangmei Chen,et al.  Potential Association of Body Constitution with the Prognosis of IgA Nephropathy: A Long-Time Follow-Up of 203 Cases in China , 2019, Evidence-based complementary and alternative medicine : eCAM.

[14]  Z. Su,et al.  Association between lifestyle, gender and risk for developing end-stage renal failure in IgA nephropathy: a case-control study within 10 years , 2019, Renal failure.

[15]  P. Fu,et al.  Analysis of the relationship between Oxford classification, IgM deposition and multiple indexes and the adverse prognosis of patients with primary IgA nephropathy and related risk factors , 2018, Experimental and therapeutic medicine.

[16]  C. Xiaojun,et al.  Traditional Chinese Medicine syndrome elements of male infertility revealed by latent tree model analysis , 2018, Journal of Traditional Chinese Medicine.

[17]  F. Schena,et al.  Epidemiology of IgA Nephropathy: A Global Perspective. , 2018, Seminars in nephrology.

[18]  L. Tang,et al.  Clinicopathological Features to Predict Progression of IgA Nephropathy with Mild Proteinuria , 2018, Kidney and Blood Pressure Research.

[19]  Mark Haas,et al.  Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group. , 2017, Kidney international.

[20]  Youming Peng,et al.  Tubular atrophy/interstitial fibrosis scores of Oxford classification combinded with proteinuria level at biopsy provides earlier risk prediction in lgA nephropathy , 2017, Scientific Reports.

[21]  Xuefeng Sun,et al.  Abelmoschus manihot – a traditional Chinese medicine versus losartan potassium for treating IgA nephropathy: study protocol for a randomized controlled trial , 2017, Trials.

[22]  Peng Xie,et al.  The new Asian modified CKD-EPI equation leads to more accurate GFR estimation in Chinese patients with CKD , 2016, International Urology and Nephrology.

[23]  J. Novak,et al.  IgA nephropathy , 2016, Nature Reviews Disease Primers.

[24]  Junping Wei,et al.  Analysis of TCM syndrome elements and relevant factors for senile diabetes , 2013 .

[25]  C. Zeng,et al.  Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[26]  B. Kasiske,et al.  KDIGO Clinical Practice Guideline for Glomerulonephritis , 2012 .

[27]  L. Thibaudin,et al.  Predicting the risk for dialysis or death in IgA nephropathy. , 2011, Journal of the American Society of Nephrology : JASN.

[28]  A. McGrogan,et al.  The incidence of primary glomerulonephritis worldwide: a systematic review of the literature. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[29]  He Li-qun Correlativity between Chinese medical syndromes and clinical prognosis of IgA nephropathy , 2010 .

[30]  Wang Dao-cheng The relation between the level of hemoglobin and differentiation of TCM in chronic heart failure and clinical effect , 2008 .

[31]  J. Scholey,et al.  Remission of proteinuria improves prognosis in IgA nephropathy. , 2007, Journal of the American Society of Nephrology : JASN.

[32]  Zhu Yan-bo Study on the Related Influencing Factors of Yang-deficiency Constitution in Chinese Medicine , 2007 .

[33]  Xiang-mei Chen,et al.  [A multi-centeric epidemiological survey on TCM syndrome in 1016 patients with IgA nephropathy and analysis of its relevant factors]. , 2006, Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.

[34]  Z. Zhang The induction of syndrome factor and affecting target , 2006 .

[35]  D. Bao The Relationship between Syndrome Differentiation of Traditional Chinese Medicine and the Degree of Pathological Changes in IgA Nephropathy Patients , 2004 .